influenza
virus
diseasecaus
agent
human
anim
reservoir
wild
bird
especi
charadriiform
anseriform
olsen
et
al
influenza
virus
classifi
use
antigen
characterist
envelop
glycoprotein
haemagglutinin
ha
neuraminidas
na
current
use
antigen
characterist
phylogenet
analysi
differ
haemagglutinin
subtyp
recogn
divid
two
lineag
figur
et
al
fouchier
et
al
tong
et
al
haemagglutinin
subtyp
two
caus
season
epidem
human
popul
howev
virus
belong
subtyp
shown
capac
aviantohuman
transmiss
spread
need
monitor
avian
mammalian
popul
pandem
prepared
peiri
achiev
use
serolog
molecular
biolog
diagnost
method
permit
identif
haemagglutinin
subtyp
cattoli
terregino
haemagglutinin
major
target
antibodi
respons
influenza
virus
trimer
envelop
glycoprotein
necessari
entri
suscept
cell
ha
monom
produc
singl
polypeptid
precursor
matur
cleav
two
subunit
process
necessari
step
acquir
fusion
activ
infect
influenza
multipl
basic
amino
acid
residu
lysin
arginin
situat
immedi
cleavag
arginin
haemagglutinin
cleav
ubiquit
express
subtilisinlik
endoproteas
furin
determin
virul
lethal
sever
avian
speci
observ
high
pathogen
avian
influenza
hpai
strain
garten
klenk
hand
cleavag
singl
arginin
lysin
amino
acid
ha
cleavag
site
low
pathogen
avian
influenza
lpai
strain
human
mammalian
influenza
virus
thought
mediat
tissuespecif
proteas
recent
differ
human
lung
proteas
belong
serin
proteas
famili
abl
cleav
haemagglutinin
human
influenza
strain
identifi
transmembran
proteas
serin
human
airway
trypsinlik
proteas
hat
et
al
bertram
et
al
date
proteas
cleav
haemagglutinin
lpai
strain
still
unidentifi
studi
ha
cleavag
human
season
strain
hat
avian
mammalian
homolog
proteas
pseudotyp
lentivir
particl
suitabl
approach
bertram
et
al
influenza
pseudotyp
particl
pp
repres
power
safe
tool
studi
antibodi
respons
direct
influenza
haemagglutinin
viral
entri
mechan
garcia
lai
present
studi
use
pseudotyp
gener
system
investig
human
role
mediat
convers
human
lpai
activ
form
show
pseudotyp
produc
effici
use
viru
neutral
assay
haemagglutinin
clone
express
plasmid
use
methodolog
describ
elsewher
temperton
et
al
haemagglutinin
ashearwaterwest
custom
synthesis
codonoptim
genscript
clone
vector
genlanti
previous
report
corti
et
al
refer
sheep
serum
provid
nation
institut
biolog
standard
control
nibsc
unit
kingdom
world
organis
anim
health
oie
avian
refer
hyperimmun
sera
produc
specif
pathogenfre
chicken
describ
elsewher
cattoli
et
al
refer
avian
sera
aafrican
provid
anim
health
veterinari
laboratori
agenc
ahvla
human
embryon
kidney
cell
cultur
dulbecco
modifi
eagl
medium
dmem
glutamax
high
glucos
gibco
invitrogen
uk
supplement
vv
fetal
bovin
serum
sigma
vv
penicillinstreptomycin
fisher
bioreag
lentivir
pseudotyp
particl
produc
describ
previous
temperton
et
al
corti
et
al
briefli
hiv
gagpol
plasmid
firefli
luciferas
express
plasmid
pcsflw
ha
express
plasmid
et
al
cotransfect
human
embryon
kidney
cell
use
transfect
reagent
roch
uk
hour
incub
recombin
neuraminidas
clostridium
perfringen
sigma
ad
figur
facilit
pseudotyp
exit
produc
cell
fortyeight
hour
posttransfect
supernat
harvest
filter
filter
store
pseudotyp
particl
also
produc
absenc
plasmid
titrat
pseudotyp
particl
perform
transduc
cell
cellswel
neat
pseudotyp
supernat
subsequ
serial
dilut
influenza
pseudotyp
titrat
absenc
presenc
tpcktrypsin
evalu
effect
endogen
express
activ
haemagglutinin
obtain
function
pseudotyp
tpcktrypsin
sigma
ad
pseudotyp
obtain
final
concentr
maintain
constant
tpcktrypsin
concentr
serial
dilut
min
trypsin
neutral
solut
lonza
ad
well
hr
luminesc
cell
cultur
rel
luminesc
unit
rlu
evalu
luminometri
use
brightglo
assay
system
promega
uk
titr
express
rluml
refer
sera
test
respect
pseudotyp
serial
dilut
cultur
media
white
flatbottom
tissu
cultur
plate
nunc
pseudotyp
supernat
ad
well
dilut
final
concentr
rluwel
cell
control
pseudotyp
sera
control
use
assay
hr
incub
sera
plu
viru
cell
ad
well
plate
incub
hr
cell
luminesc
measur
describ
result
normal
express
percentag
inhibit
pseudotyp
viru
entri
neutral
use
cell
pseudotyp
control
rlu
valu
half
maxim
inhibitori
concentr
inhibitori
concentr
calcul
prism
version
graphpad
softwar
titr
influenza
pseudotyp
particl
express
rluml
shown
figur
cotransfect
success
obtain
hightitr
viral
pseudotyp
particl
harbour
haemagglutinin
human
viru
ashearwaterwest
lpai
viru
notabl
pseudotyp
produc
titr
rluml
pseudotyp
particl
titr
obtain
transfect
compar
control
influenza
pseudotyp
tpcktrypsin
activ
influenza
pseudotyp
pseudotyp
particl
produc
without
ha
envelop
protein
data
indic
activ
haemagglutinin
human
strain
also
haemagglutinin
avian
influenza
strain
lpai
subtyp
similar
manner
tpcktrypsin
test
neutral
assay
pseudotyp
particl
effici
neutral
pair
antisera
tabl
use
cutoff
dilut
except
pseudotyp
effici
neutral
sheep
serum
moder
neutral
sera
avian
origin
differ
neutral
profil
also
observ
differ
antisera
exhibit
least
potent
neutral
activ
shown
essenti
role
product
hightitr
influenza
pseudotyp
particl
proteas
coexpress
viru
product
mediat
haemagglutinin
activ
human
influenza
lpai
viru
strain
enabl
function
pseudotyp
particl
titr
compar
higher
one
achiev
tpcktrypsin
treatment
sinc
proteas
abl
cleav
human
influenza
haemagglutinin
et
al
tpcktrypsin
abl
activ
haemagglutinin
proteolit
cleavag
assum
activ
ha
pseudotyp
particl
specif
cleavag
fact
human
abl
activ
probabl
cleavag
differ
influenza
subtyp
reinforc
concept
haemagglutinin
cleavag
conserv
process
avian
speci
human
highlight
observ
homolog
protein
abl
cleav
human
influenza
ha
bertram
et
al
howev
studi
need
perform
determin
function
proteas
eg
hat
haemagglutinin
activ
cleavag
examin
cleavag
kinet
understand
haemagglutinin
amino
acid
residu
involv
haemagglutininproteas
interact
furthermor
interest
evalu
abil
activ
lpai
influenza
haemagglutinin
subtyp
sinc
proteas
abl
cleav
human
subtyp
et
al
similarli
produc
pseudotyp
report
literatur
wang
et
al
corti
et
al
present
studi
show
although
human
activ
haemagglutinin
differ
subtyp
clear
differ
titr
observ
subtyp
depend
differenti
ha
express
matur
glycosyl
endoplasm
reticulum
golgi
apparatu
traffick
produc
cell
line
ueda
et
al
differenti
recognit
cleavag
differ
subtyp
haemagglutinin
influenza
haemagglutinin
use
studi
character
cleavag
motif
p
e
g
k
v
xx
k
r
number
physicochem
properti
central
aminoacid
residu
prolin
cleavag
argininelysin
variabl
subtyp
pekqtr
pekasr
pgkqak
peipkgr
pekirtr
pevvqgr
recent
structur
subtyp
haemagglutinin
resolv
observ
amino
acid
residu
upstream
cleavag
site
import
determin
surfac
access
cleavag
arginin
lu
et
al
similar
process
could
explain
slightli
lower
titr
observ
pseudotyp
haemagglutinin
subtyp
character
singl
lysin
cleavag
site
pgkqak
kawaoka
et
al
amino
acid
residu
upstream
cleavag
site
pekirtr
differ
close
relat
subtyp
peipkgr
et
al
resolv
human
protein
structur
cocrystal
human
andor
avian
haemagglutinin
could
valuabl
delin
amino
acid
residu
involv
cleavag
process
would
enhanc
understand
haemagglutinin
activ
mechan
importantli
may
aid
develop
potenti
proteas
inhibitor
zhirnov
et
al
et
al
similar
manner
neuraminidas
inhibitor
design
treatment
sever
influenza
viru
infect
panel
influenza
pseudotyp
describ
paper
addit
previous
produc
could
util
tool
test
activ
compound
preclin
screen
phase
influenza
pseudotyp
particl
could
also
use
studi
antibodi
respons
direct
haemagglutinin
serolog
method
haemagglutin
inhibit
microneutr
costeffect
widelyus
methodolog
monitor
circul
preval
influenza
virus
also
employ
vaccin
efficaci
studi
cattoli
terregino
report
demonstr
refer
influenza
antisera
abl
effici
neutral
haemagglutininpair
influenza
pseudotyp
particl
previous
demonstr
influenza
pseudotyp
particl
neutral
assay
correl
classic
serolog
assay
temperton
et
al
alberini
et
al
garcia
et
al
may
becom
techniqu
choic
hpai
viru
serolog
addit
sinc
pseudotyp
describ
replicationdefect
offer
safe
altern
wild
type
viru
method
requir
biosafeti
level
contain
detect
antibodi
respons
influenc
variabl
bloodbas
reagent
observ
assay
ie
erythrocyt
haemagglutin
inhibit
row
et
al
furthermor
pseudotyp
neutral
assay
appear
effect
function
assay
detect
antibodi
respons
direct
haemagglutinin
stalk
corti
et
al
like
due
fact
absenc
neuraminidas
pseudotyp
particl
membran
surfac
glycoprotein
densiti
reduc
ha
stalk
thu
becom
access
antibodi
consequ
pseudotyp
could
use
effect
studi
heterosubtyp
antibodi
respons
direct
ha
stalk
region
studi
product
influenza
pseudotyp
present
proofofprincipl
use
surrog
antigen
antibodi
neutral
assay
demonstr
refer
influenza
antisera
effici
neutral
match
pseudotyp
interestingli
human
pseudotyp
effici
neutral
pair
avian
antisera
compar
sheep
antisera
probabl
due
fact
avian
virus
belong
differ
lineag
respect
human
zhang
et
al
variat
antisera
neutral
titr
also
observ
antisera
test
relat
origin
antisera
gener
differ
viru
strain
pseudotyp
strain
also
may
reflect
intrasubtyp
antigen
differ
among
strain
furthermor
differ
antisera
prepar
probabl
differ
neutral
titr
viral
strain
overal
result
present
reinforc
greater
sensit
pseudotyp
particl
neutral
assay
describ
previous
temperton
et
al
garcia
et
al
neutral
assay
use
influenza
pseudotyp
particl
provid
addit
impetu
optimis
standardis
valid
technolog
method
use
surveil
influenza
virus
anim
human
present
studi
shown
